🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single dose, randomised, cross-over study to confirm...
Status
Completed
Location
West Hospital, Sichuan University
Start Date
2017-06-30
Trial ID
NCT03398278
Treatments Being Tested
PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Status
Completed
Location
PRA Health Sciences - Early Development Services
Start Date
2016-11-16
Trial ID
NCT02454712
Treatments Being Tested
This is a multi-centre, long term, double blind, clinical protocol for Nana...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11
Trial ID
NCT04808531
Treatments Being Tested
The purpose of this study is to assess the bioequivalence of a new oxycodon...
Status
Completed
Location
Covance Clinical Research Unit - Evansville
Start Date
2007-02
Trial ID
NCT01101165
Treatments Being Tested
The objective of this open-label, randomized, two-period, crossover study w...
Status
Completed
Location
Bio-Kinetic Clinical Applications
Start Date
2005-04
Trial ID
NCT00853892
Treatments Being Tested
A clinical, multicenter, randomized, parallel-group, double-blind, double-d...
Status
Completed
Location
Eurofarma Laboratorios S.A
Start Date
2024-03-27
Trial ID
NCT05081102
Treatments Being Tested
The objective of this open-label, randomized, two-period, crossover study w...
Status
Completed
Location
Bio-Kinetic Clinical Applications
Start Date
2005-04
Trial ID
NCT00853268
Treatments Being Tested
To assess the bioequivalence of reformulated OXY tablets (40 mg) relative t...
Status
Completed
Location
Covance Clinical Research Unit - Austin
Start Date
2007-01
Trial ID
NCT01100320
Treatments Being Tested
An open-label, single dose, randomized, cross-over study to confirm the bio...
Status
Completed
Location
Xiangya Hospital of Central South University
Start Date
2017-03-16
Trial ID
NCT03398330
Treatments Being Tested